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Intracellular signalling by NO/cGMP-dependent protein
kinase type I (cGKI) relaxes smooth muscles thereby mod-
ulating e.g. vascular tone. An important mediator of this
signalling cascade is the inositol 1,4,5,-trisphosphate
receptor I (IP3 RI) associated protein cGMP kinase sub-
strate (IRAG). This protein forms a trimeric complex
together with the cGMP kinase Iβ and the IP3 RI. Recently,
it was shown that the relaxation of hormone-contracted
aortic smooth muscle by cGMP was abolished in IRAG
Δ12/Δ12 mutant mice with a disrupted IRAG-IP3 RI interac-
tion site [1]. Now we investigated whether IRAG might
regulate the vascular tone in small vessels. NO-mediated
relaxation of isolated arteria tibialis was nearly absent in
the IRAG mutant. Moreover, the relaxing effect of IRAG on
NO-mediated dilation of resistance vessels in perfused
hind limbs of mutant mice was abolished.
To analyze the in vivio function of IRAG/IP3 RI interac-
tion, we finally recorded blood pressure in conscious,
freely moving animals via implanted radiotelemetric
devices. After application of NO-donors blood pressure
decrease was clearly diminished in IRAGΔ12/Δ12 mutants
compared to control mice.
These data suggest that IRAG is essential for NO/cGMP-
dependent relaxation of vascular smooth muscle.
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